anti-ACVR1 / ALK2 antibody

Key features and details

  • 产品描述: Goat Polyclonal antibody recognizes ACVR1 / ALK2
  • 反应物种: Hu
  • 预测物种: Ms, Rat, Dog
  • 应用: IHC-P, WB
  • 宿主: Goat
  • 克隆: Polyclonal
  • 同位型: IgG
  • 靶点名称: ACVR1 / ALK2
  • 抗原物种: Human
  • Brand:
CAT.NO. : ARG64410
US$ Please choose
US$ Please choose
Size:
Trail, Bulk size or Custom requests Please contact us
*产品价格可能会有所调整,请以品牌方官网实时更新的价格为准,以确保准确性。
Product Details
概述
产品描述Goat Polyclonal antibody recognizes ACVR1 / ALK2
反应物种Hu
预测物种Ms, Rat, Dog
应用IHC-P, WB
宿主Goat
克隆Polyclonal
同位型IgG
靶点名称ACVR1 / ALK2
抗原物种Human
抗原C-RKFKRRNQERLNPRD
偶联标记Un-conjugated
別名ALK2; ACTRI; FOP; Serine/threonine-protein kinase receptor R1; Activin receptor type I; EC 2.7.11.30; Activin receptor-like kinase 2; TSRI; ACVRLK2; Activin receptor type-1; SKR1; ACVR1A; ACTR-I; TGF-B superfamily receptor type I; TSR-I; ALK-2
应用说明
应用建议
应用推荐稀释比
IHC-P4 - 6 µg/ml
WB0.3 - 1 µg/ml
应用说明IHC-P: Antigen Retrieval: Steam tissue section in Citrate buffer (pH 6.0).
WB: Recommend incubate at RT for 1h.
* The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.
属性
形式Liquid
纯化Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
缓冲液Tris saline (pH 7.3), 0.02% Sodium azide and 0.5% BSA
抗菌剂0.02% Sodium azide
稳定剂0.5% BSA
浓度0.5 mg/ml
存放说明For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
注意事项For laboratory research only, not for drug, diagnostic or other use.
生物信息
数据库连接

GeneID: 90 Human ACVR1

Swiss-port # Q04771 Human Activin receptor type-1

基因名称ACVR1
全名activin A receptor type 1
背景介绍Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]
研究领域Developmental Biology antibody; Gene Regulation antibody; Signaling Transduction antibody
预测分子量57 kDa
检测图片 (2)
  • ARG64410 anti-ACVR1 / ALK2 antibody IHC-P image

    Immunohistochemistry: Paraffin-embedded Human testis (steamed antigen retrieval with citrate buffer pH 6.0) stained with ARG64410 anti-ACVR1 / ALK2 antibody at 4 µg/ml dilution followed by AP-staining.

  • ARG64410 anti-ACVR1 / ALK2 antibody WB image

    Western blot: 35 µg of Human umbilical cord lysate (in RIPA buffer) stained with ARG64410 anti-ACVR1 / ALK2 antibody at 0.3 µg/ml dilution and incubated at RT for 1 hour.

New Products
Get in touch with AREX
Name:*
Tel/Phone:*
Company:*
Email:*
Inquiry:
Captcha*
Submitting your email information means that you are willing to receive email information from AREX regarding technology, applications, products, and events. By clicking on the 'unsubscribe' button in the email or by contacting info@arexbio.com You can unsubscribe at any time by sending an email. Regarding your data usage information, please refer to our privacy policy.
© AREX 2024. All Rights Reserved. | 浙ICP备2024113709号-3 Sitemap